FDA Approval: ALS Trial (VIDEO) Michigan Medicine - University of Michigan This video is under embargo. Please login to access this video. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Caption Dr. Eva Feldman of the University of Michigan discusses the FDA approval of a Phase II clinical trial of stem cell injections for patients with ALS, also known as Lou Gehrig's disease. Credit University of Michigan/Logan6 Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.